Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 330

1.

Machine Learning to Predict the Likelihood of Acute Myocardial Infarction.

Than MP, Pickering JW, Sandoval Y, Shah ASV, Tsanas A, Apple FS, Blankenberg S, Cullen L, Mueller C, Neumann JT, Twerenbold R, Westermann D, Beshiri A, Mills NL; MI3 collaborative.

Circulation. 2019 Aug 16. doi: 10.1161/CIRCULATIONAHA.119.041980. [Epub ahead of print]

PMID:
31416346
2.

Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays: A Practical Approach for Clinicians.

McCarthy CP, Raber I, Chapman AR, Sandoval Y, Apple FS, Mills NL, Januzzi JL Jr.

JAMA Cardiol. 2019 Aug 7. doi: 10.1001/jamacardio.2019.2724. [Epub ahead of print]

PMID:
31389986
3.

Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Biomarkers.

Kavsak PA, Lam CSP, Saenger AK, Jaffe AS, Collinson P, Pulkki K, Omland T, Lefèvre G, Body R, Ordonez-Llanos J, Apple FS.

Clin Chem. 2019 Aug 6. pii: clinchem.2019.306621. doi: 10.1373/clinchem.2019.306621. [Epub ahead of print]

PMID:
31387884
4.

Role of BNP vs NT-proBNP Testing in the Age of New Drug Therapies: Sacubitril-Valsartan.

Apple FS, Daniels LB, Januzzi J, Omland T, Ordonez-Llanos J, Jaffe A.

Clin Chem. 2019 Sep;65(9):1076-1083. doi: 10.1373/clinchem.2018.289371. Epub 2019 Jul 18. No abstract available.

PMID:
31320381
5.

Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I.

Sandoval Y, Nowak R, deFilippi CR, Christenson RH, Peacock WF, McCord J, Limkakeng AT, Sexter A, Apple FS.

J Am Coll Cardiol. 2019 Jul 23;74(3):271-282. doi: 10.1016/j.jacc.2019.05.058.

PMID:
31319909
6.

Clinical Features and Outcomes of Emergency Department Patients With High-Sensitivity Cardiac Troponin I Concentrations Within Sex-Specific Reference Intervals.

Sandoval Y, Smith SW, Sexter A, Gunsolus IL, Schulz K, Apple FS.

Circulation. 2019 Apr 2;139(14):1753-1755. doi: 10.1161/CIRCULATIONAHA.118.038284. No abstract available.

PMID:
30933618
7.

Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.

Ibrahim NE, McCarthy CP, Shrestha S, Gaggin HK, Mukai R, Szymonifka J, Apple FS, Burnett JC Jr, Iyer S, Januzzi JL Jr.

J Am Coll Cardiol. 2019 Mar 26;73(11):1273-1284. doi: 10.1016/j.jacc.2018.12.063.

PMID:
30898202
8.

Appropriateness of Cardiac Troponin Testing: Insights from the Use of TROPonin In Acute coronary syndromes (UTROPIA) Study.

Sandoval Y, Gunsolus IL, Smith SW, Sexter A, Thordsen SE, Carlson MD, Johnson BK, Bruen CA, Dodd KW, Driver BE, Jacoby K, Love SA, Moore JC, Scott NL, Schulz K, Apple FS.

Am J Med. 2019 Jul;132(7):869-874. doi: 10.1016/j.amjmed.2019.01.043. Epub 2019 Mar 5.

PMID:
30849383
9.

Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study.

Christenson RH, Peacock WF, Apple FS, Limkakeng AT Jr, Nowak RM, McCord J, deFilippi CR.

Contemp Clin Trials Commun. 2019 Feb 15;14:100337. doi: 10.1016/j.conctc.2019.100337. eCollection 2019 Jun.

10.

Susceptibility of Cardiac Troponin Assays to Biotin Interference.

Frame IJ, Joshi PH, Mwangi C, Gunsolus I, De Lemos JA, Das SR, Sarode R, Balani J, Apple FS, Muthukumar A.

Am J Clin Pathol. 2019 Apr 2;151(5):486-493. doi: 10.1093/ajcp/aqy172.

PMID:
30715102
12.

High sensitivity, contemporary and point-of-care cardiac troponin assays: educational aids developed by the IFCC Committee on Clinical Application of Cardiac Bio-Markers.

Collinson PO, Saenger AK, Apple FS; IFCC C-CB.

Clin Chem Lab Med. 2019 Apr 24;57(5):623-632. doi: 10.1515/cclm-2018-1211.

13.

Clinical use of cardiac troponin for acute cardiac care and emerging opportunities in the outpatient setting.

Sandoval Y, Sharain K, Saenger AK, Smith SW, Apple FS, Jaffe AS.

Minerva Med. 2019 Apr;110(2):139-156. doi: 10.23736/S0026-4806.18.05874-3. Epub 2018 Nov 27. Review.

PMID:
30484592
14.

Risk Estimation in Type 2 Myocardial Infarction and Myocardial Injury: The TARRACO Risk Score.

Cediel G, Sandoval Y, Sexter A, Carrasquer A, González-Del-Hoyo M, Bonet G, Boqué C, Schulz K, Smith SW, Bayes-Genis A, Apple FS, Bardaji A.

Am J Med. 2019 Feb;132(2):217-226. doi: 10.1016/j.amjmed.2018.10.022. Epub 2018 Nov 9.

PMID:
30419227
15.

[Fourth universal definition of myocardial infarction (2018)].

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL Jr, Apple FS, Alonso Garcia MA, Underwood SR, Canty JM Jr, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B, Weintraub WS, Newby LK, Virmani R, Vranckx P, Cutlip D, Gibbons RJ, Smith SC, Atar D, Luepker RV, Robertson RM, Bonow RO, Steg PG, O'Gara PT, Fox KAA.

Kardiol Pol. 2018;76(10):1383-1415. doi: 10.5603/KP.2018.0203. Polish. No abstract available.

16.

Endurance Exercise Training Attenuates Natriuretic Peptide Release During Maximal Effort Exercise: Biochemical Correlates of the "Athlete's Heart".

Shah AB, Zilinski J, Brown MG, Neary JH, Weiner RB, Hutter AM, Apple FS, Picard MH, Januzzi JL, Baggish AL.

J Appl Physiol (1985). 2018 Oct 11. doi: 10.1152/japplphysiol.00293.2018. [Epub ahead of print]

PMID:
30307785
17.

Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB).

Saenger AK, Jaffe AS, Body R, Collinson PO, Kavsak PA, Lam CSP, Lefèvre G, Omland T, Ordóñez-Llanos J, Pulkki K, Apple FS.

Clin Chem Lab Med. 2019 Apr 24;57(5):633-640. doi: 10.1515/cclm-2018-0905.

18.

Multicenter assessment of a hemoglobin A1c point-of-care device for diagnosis of diabetes mellitus.

Sobolesky PM, Smith BE, Saenger AK, Schulz K, Apple FS, Scott MG, Wu AHB, Little RR, Fitzgerald RL.

Clin Biochem. 2018 Nov;61:18-22. doi: 10.1016/j.clinbiochem.2018.09.007. Epub 2018 Sep 17.

PMID:
30236830
19.

High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial.

Shah ASV, Anand A, Strachan FE, Ferry AV, Lee KK, Chapman AR, Sandeman D, Stables CL, Adamson PD, Andrews JPM, Anwar MS, Hung J, Moss AJ, O'Brien R, Berry C, Findlay I, Walker S, Cruickshank A, Reid A, Gray A, Collinson PO, Apple FS, McAllister DA, Maguire D, Fox KAA, Newby DE, Tuck C, Harkess R, Parker RA, Keerie C, Weir CJ, Mills NL; High-STEACS Investigators.

Lancet. 2018 Sep 15;392(10151):919-928. doi: 10.1016/S0140-6736(18)31923-8. Epub 2018 Aug 28.

20.

Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.

Sandoval Y, Smith SW, Sexter A, Schulz K, Apple FS.

Eur Heart J Acute Cardiovasc Care. 2018 Jul 1:2048872618787796. doi: 10.1177/2048872618787796. [Epub ahead of print]

PMID:
29979092
21.

Copeptin to rule out myocardial infarction in Blacks versus Caucasians.

Beri N, Daniels LB, Jaffe A, Mueller C, Anand I, Peacock WF, Hollander JE, DeFilippi C, Schreiber D, McCord J, Limkakeng AT, Wu AHB, Apple FS, Diercks DB, Nagurney JT, Nowak RM, Cannon CM, Clopton P, Neath SX, Christenson RH, Hogan C, Vilke G, Maisel A.

Eur Heart J Acute Cardiovasc Care. 2019 Aug;8(5):395-403. doi: 10.1177/2048872618772500. Epub 2018 May 8.

PMID:
29737180
22.

Science Moves Slowly.

Jaffe AS, Apple FS.

J Am Coll Cardiol. 2018 Apr 10;71(14):1550-1552. doi: 10.1016/j.jacc.2018.01.068. No abstract available.

24.

Low pO2 Contributes to Potential Error in Oxygen Saturation Calculations Using a Point-of-Care Assay.

Gunsolus IL, Love SA, Kohl LP, Schmidt M, Apple FS.

Am J Clin Pathol. 2017 Dec 20;149(1):82-86. doi: 10.1093/ajcp/aqx152.

PMID:
29228083
25.

Reply to letter by Trupp et al.

Apple FS, Saenger AK, Gunsolus IL, Love SA, Jaffe AS.

Clin Biochem. 2018 Feb;52:174. doi: 10.1016/j.clinbiochem.2017.11.012. Epub 2017 Nov 21. No abstract available.

PMID:
29162471
26.

Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome.

Chapman AR, Lee KK, McAllister DA, Cullen L, Greenslade JH, Parsonage W, Worster A, Kavsak PA, Blankenberg S, Neumann J, Sörensen NA, Westermann D, Buijs MM, Verdel GJE, Pickering JW, Than MP, Twerenbold R, Badertscher P, Sabti Z, Mueller C, Anand A, Adamson P, Strachan FE, Ferry A, Sandeman D, Gray A, Body R, Keevil B, Carlton E, Greaves K, Korley FK, Metkus TS, Sandoval Y, Apple FS, Newby DE, Shah ASV, Mills NL.

JAMA. 2017 Nov 21;318(19):1913-1924. doi: 10.1001/jama.2017.17488. Review. Erratum in: JAMA. 2018 Mar 20;319(11):1168. Soerensen NA [corrected to Sorensen NA].

27.

Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study.

Shah ASV, Sandoval Y, Noaman A, Sexter A, Vaswani A, Smith SW, Gibbins M, Griffiths M, Chapman AR, Strachan FE, Anand A, Denvir MA, Adamson PD, D'Souza MS, Gray AJ, McAllister DA, Newby DE, Apple FS, Mills NL.

BMJ. 2017 Nov 7;359:j4788. doi: 10.1136/bmj.j4788. Erratum in: BMJ. 2018 Jan 31;360:k495.

28.

Renal Dysfunction Influences the Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin I.

Gunsolus I, Sandoval Y, Smith SW, Sexter A, Schulz K, Herzog CA, Apple FS.

J Am Soc Nephrol. 2018 Feb;29(2):636-643. doi: 10.1681/ASN.2017030341. Epub 2017 Oct 27.

29.

Commentary.

Apple FS.

Clin Chem. 2017 Oct;63(10):1573-1574. doi: 10.1373/clinchem.2016.270033. No abstract available.

30.

Sex-specific 99th percentiles derived from the AACC Universal Sample Bank for the Roche Gen 5 cTnT assay: Comorbidities and statistical methods influence derivation of reference limits.

Gunsolus IL, Jaffe AS, Sexter A, Schulz K, Ler R, Lindgren B, Saenger AK, Love SA, Apple FS.

Clin Biochem. 2017 Dec;50(18):1073-1077. doi: 10.1016/j.clinbiochem.2017.09.009. Epub 2017 Sep 13.

PMID:
28916437
31.

Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High-Sensitivity Cardiac Troponin I.

Sandoval Y, Smith SW, Sexter A, Thordsen SE, Bruen CA, Carlson MD, Dodd KW, Driver BE, Hu Y, Jacoby K, Johnson BK, Love SA, Moore JC, Schulz K, Scott NL, Apple FS.

Am J Med. 2017 Dec;130(12):1431-1439.e4. doi: 10.1016/j.amjmed.2017.05.049. Epub 2017 Jul 21.

PMID:
28739197
32.

High-Sensitivity Cardiac Troponin T Improves the Diagnosis of Perioperative MI.

Brown JC, Samaha E, Rao S, Helwani MA, Duma A, Brown F, Gage BF, Miller JP, Jaffe AS, Apple FS, Scott MG, Nagele P.

Anesth Analg. 2017 Nov;125(5):1455-1462. doi: 10.1213/ANE.0000000000002240.

33.

The new face of heroin.

Olives TD, Arens AM, Kloss JS, Apple FS, Cole JB.

Am J Emerg Med. 2017 Dec;35(12):1978-1979. doi: 10.1016/j.ajem.2017.06.042. Epub 2017 Jun 21. No abstract available.

PMID:
28716592
34.

Diagnostic Performance of High Sensitivity Compared with Contemporary Cardiac Troponin I for the Diagnosis of Acute Myocardial Infarction.

Sandoval Y, Smith SW, Thordsen SE, Bruen CA, Carlson MD, Dodd KW, Driver BE, Jacoby K, Johnson BK, Love SA, Moore JC, Sexter A, Schulz K, Scott NL, Nicholson J, Apple FS.

Clin Chem. 2017 Oct;63(10):1594-1604. doi: 10.1373/clinchem.2017.272930. Epub 2017 Jul 12.

35.

In Reply.

Apple FS, Sandoval Y, Jaffe AS.

Clin Chem. 2017 Jun;63(6):1167-1170. doi: 10.1373/clinchem.2017.273250. Epub 2017 Apr 20. No abstract available.

36.

Heroin-related Deaths from the Hennepin County Medical Examiner's Office from 2004 Through 2015.

Love SA, Lelinski J, Kloss J, Middleton O, Apple FS.

J Forensic Sci. 2018 Jan;63(1):191-194. doi: 10.1111/1556-4029.13511. Epub 2017 Apr 19.

PMID:
28422290
37.

Single High-Sensitivity Cardiac Troponin I to Rule Out Acute Myocardial Infarction.

Sandoval Y, Smith SW, Love SA, Sexter A, Schulz K, Apple FS.

Am J Med. 2017 Sep;130(9):1076-1083.e1. doi: 10.1016/j.amjmed.2017.02.032. Epub 2017 Mar 24.

PMID:
28344141
38.

Total Analytic Error for Low Cardiac Troponin Concentrations (≤10 ng/L) by Use of a High-Sensitivity Cardiac Troponin Assay.

Kavsak PA, Jaffe AS, Greene DN, Christenson RH, Apple FS, Wu AHB.

Clin Chem. 2017 May;63(5):1043-1045. doi: 10.1373/clinchem.2017.271361. Epub 2017 Mar 21. No abstract available.

39.

Use of the HEART Pathway with high sensitivity cardiac troponins: A secondary analysis.

Mahler SA, Stopyra JP, Apple FS, Riley RF, Russell GB, Hiestand BC, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Herrington DM, Burke GL, Miller CD.

Clin Biochem. 2017 May;50(7-8):401-407. doi: 10.1016/j.clinbiochem.2017.01.003. Epub 2017 Jan 10.

40.

Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides.

Saenger AK, Rodriguez-Fraga O, Ler R, Ordonez-Llanos J, Jaffe AS, Goetze JP, Apple FS.

Clin Chem. 2017 Jan;63(1):351-358. doi: 10.1373/clinchem.2016.263749. Epub 2016 Nov 15.

41.

Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care.

Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J; IFCC Task Force on Clinical Applications of Cardiac Bio-Markers.

Clin Chem. 2017 Jan;63(1):73-81. doi: 10.1373/clinchem.2016.255109. Epub 2016 Oct 10. Review.

42.

Best Practices for Monitoring Cardiac Troponin in Detecting Myocardial Injury.

Apple FS, Jaffe AS, Sharkey S, Kavsak P, Kontos MC, Saenger AK, Smith S.

Clin Chem. 2017 Jan;63(1):37-44. doi: 10.1373/clinchem.2016.257428. Epub 2016 Oct 6. No abstract available.

43.

Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics.

Apple FS, Cullen L, Felker GM, Ginsburg G, Morrow D.

Clin Chem. 2017 Jan;63(1):1-4. doi: 10.1373/clinchem.2016.263350. No abstract available.

44.

Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.

Kopec M, Duma A, Helwani MA, Brown J, Brown F, Gage BF, Gibson DW, Miller JP, Novak E, Jaffe AS, Apple FS, Scott MG, Nagele P.

Anesth Analg. 2017 Feb;124(2):398-405. doi: 10.1213/ANE.0000000000001736.

45.

Necessity of hospitalization and stress testing in low risk chest pain patients.

Beri N, Marston NA, Daniels LB, Nowak RM, Schreiber D, Mueller C, Jaffe A, Diercks DB, Wettersten N, DeFilippi C, Peacock WF, Limkakeng AT, Anand I, McCord J, Hollander JE, Wu AHB, Apple FS, Nagurney JT, Berardi C, Cannon CM, Clopton P, Neath SX, Christenson RH, Hogan C, Vilke G, Maisel A.

Am J Emerg Med. 2017 Feb;35(2):274-280. doi: 10.1016/j.ajem.2016.10.072. Epub 2016 Oct 29.

PMID:
27847253
46.

Searching for a BNP standard: Glycosylated proBNP as a common calibrator enables improved comparability of commercial BNP immunoassays.

Semenov AG, Tamm NN, Apple FS, Schulz KM, Love SA, Ler R, Feygina EE, Katrukha AG.

Clin Biochem. 2017 Mar;50(4-5):181-185. doi: 10.1016/j.clinbiochem.2016.11.003. Epub 2016 Nov 5.

47.

Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction.

Díaz-Garzón J, Sandoval Y, Smith SW, Love S, Schulz K, Thordsen SE, Johnson BK, Driver B, Jacoby K, Carlson MD, Dodd KW, Moore J, Scott NL, Bruen CA, Hatch R, Apple FS.

Clin Chem. 2017 Jan;63(1):415-419. doi: 10.1373/clinchem.2016.263764. Epub 2016 Nov 3.

48.

Rapid Rule-Out of Acute Myocardial Injury Using a Single High-Sensitivity Cardiac Troponin I Measurement.

Sandoval Y, Smith SW, Shah AS, Anand A, Chapman AR, Love SA, Schulz K, Cao J, Mills NL, Apple FS.

Clin Chem. 2017 Jan;63(1):369-376. doi: 10.1373/clinchem.2016.264523. Epub 2016 Nov 3.

49.

Urine Creatinine Concentrations in Drug Monitoring Participants and Hospitalized Patients.

Love SA, Seegmiller JC, Kloss J, Apple FS.

J Anal Toxicol. 2016 Oct;40(8):659-662. Epub 2016 Sep 1.

PMID:
27590035
50.

The applied statistical approach highly influences the 99th percentile of cardiac troponin I.

Eggers KM, Apple FS, Lind L, Lindahl B.

Clin Biochem. 2016 Oct;49(15):1109-1112. doi: 10.1016/j.clinbiochem.2016.08.012. Epub 2016 Aug 21.

PMID:
27556285

Supplemental Content

Loading ...
Support Center